These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23514536)

  • 21. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
    Bi S; Earl LA; Jacobs L; Baum LG
    J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-7 in Epithelial Homeostasis and Carcinomas.
    Advedissian T; Deshayes F; Viguier M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIM-3 and its regulatory role in immune responses.
    Zhu C; Anderson AC; Kuchroo VK
    Curr Top Microbiol Immunol; 2011; 350():1-15. PubMed ID: 20700701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tim-2 up-regulation and galectin-9-Tim-3 pathway activation in Th2-biased response in Schistosoma japonicum infection in mice.
    Qi Y; Song XR; Shen JL; Xu YH; Shen Q; Luo QL; Zhong ZR; Wang W; Chu DY; Song WJ
    Immunol Lett; 2012 May; 144(1-2):60-6. PubMed ID: 22469568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-9: A Suppressor of Atherosclerosis?
    Yu J; Zhu R; Yu K; Wang Y; Ding Y; Zhong Y; Zeng Q
    Front Immunol; 2020; 11():604265. PubMed ID: 33250901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.
    Mengshol JA; Golden-Mason L; Arikawa T; Smith M; Niki T; McWilliams R; Randall JA; McMahan R; Zimmerman MA; Rangachari M; Dobrinskikh E; Busson P; Polyak SJ; Hirashima M; Rosen HR
    PLoS One; 2010 Mar; 5(3):e9504. PubMed ID: 20209097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Galectins in Allergic Disorders.
    Kucuksezer UC; Ozdemir C
    Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):2-12. PubMed ID: 27112441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-9 in physiological and pathological conditions.
    Hirashima M; Kashio Y; Nishi N; Yamauchi A; Imaizumi TA; Kageshita T; Saita N; Nakamura T
    Glycoconj J; 2002; 19(7-9):593-600. PubMed ID: 14758084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional role of galectin-9 in directing human innate immune reactions to Gram-negative bacteria and T cell apoptosis.
    Schlichtner S; Meyer NH; Yasinska IM; Aliu N; Berger SM; Gibbs BF; Fasler-Kan E; Sumbayev VV
    Int Immunopharmacol; 2021 Nov; 100():108155. PubMed ID: 34543981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation.
    Niwa H; Satoh T; Matsushima Y; Hosoya K; Saeki K; Niki T; Hirashima M; Yokozeki H
    Clin Immunol; 2009 Aug; 132(2):184-94. PubMed ID: 19464955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation.
    Sturm A; Lensch M; André S; Kaltner H; Wiedenmann B; Rosewicz S; Dignass AU; Gabius HJ
    J Immunol; 2004 Sep; 173(6):3825-37. PubMed ID: 15356130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis.
    Sakai K; Kawata E; Ashihara E; Nakagawa Y; Yamauchi A; Yao H; Nagao R; Tanaka R; Yokota A; Takeuchi M; Hirai H; Kimura S; Hirashima M; Yoshimura N; Maekawa T
    Eur J Immunol; 2011 Jan; 41(1):67-75. PubMed ID: 21182078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
    Gao L; Yu S; Zhang X
    Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of full-length Toxascaris leonina galectin with two carbohydrate-recognition domains.
    Jeong MS; Hwang HG; Yu HS; Jang SB
    Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):168-75. PubMed ID: 23385453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.
    Wang F; He W; Yuan J; Wu K; Zhou H; Zhang W; Chen ZK
    Transpl Immunol; 2008 Apr; 19(1):12-9. PubMed ID: 18346632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis.
    Méndez-Huergo SP; Blidner AG; Rabinovich GA
    Curr Opin Immunol; 2017 Apr; 45():8-15. PubMed ID: 28088061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
    Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
    Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin multimerization and lattice formation are regulated by linker region structure.
    Earl LA; Bi S; Baum LG
    Glycobiology; 2011 Jan; 21(1):6-12. PubMed ID: 20864568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Galectin-7 in Cancer.
    Kaur M; Kaur T; Kamboj SS; Singh J
    Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.